Sbn Texofab India Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
- Paid Up Capital ₹ 2.10 M
- Company Age 1 Year 7 Months
- Open Charges ₹ 6.45 Cr
About Sbn Texofab India
Sbn Texofab India Private Limited (STIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2023 (One year and seven months 2 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Mining Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 2.10 M.
The company currently has active open charges totaling ₹6.45 Cr.
Suresh Gupta, Ranjana Mittal, and Balbir Gupta serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U13134GJ2023PTC142935
-
Company No.
142935
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jul 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sbn Texofab India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Gupta
|
Director | 14-Jul-2023 | Current |
|
Ranjana Mittal
|
Additional Director | 18-Nov-2023 | Current |
|
Balbir Gupta
|
Director | 14-Jul-2023 | Current |
Financial Performance of Sbn Texofab India.
Enhance accessibility to Sbn Texofab India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sbn Texofab India?
Unlock access to Sbn Texofab India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Badshah Woollen Mills Pvt LtdSuresh Gupta is a mutual person
Charges (Loans)
₹64.52 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.45 Cr
- Hdb Financial Services Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Feb 2024 | Hdfc Bank Limited | ₹1.02 M | Open |
| 08 Jan 2024 | Hdfc Bank Limited | ₹4.35 Cr | Open |
| 18 Oct 2023 | Hdb Financial Services Limited | ₹2.00 Cr | Open |
How Many Employees Work at Sbn Texofab India?
Unlock and access historical data on people associated with Sbn Texofab India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sbn Texofab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sbn Texofab India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.